A national conversation with an unparalleled look into the leading minds that are shaping today's COVID-19 public health decisions, and the emergence of a new normal.... more
Share Findmyvaccine
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Findmyvaccine
By findmyvaccine, Pharmacy Leaders of Tomorrow
FAQs about Findmyvaccine:
How many episodes does Findmyvaccine have?
The podcast currently has 25 episodes available.
Findmyvaccine episodes:
September 09, 2024COVID-19 Fall Update: A New Variant and the Big Update on Strain Selection with Dr.Zain Chagla ๐๏ธFindMyVaccine is back with infectious diseases physician, Dr. Zain Chagla, who joins us from Toronto in studio.
As we head into Fall 2024, it's not just the leaves changing-we cover the latest updates on COVID-19, new variants, new boosters, and new messaging we head into respiratory season.ย ๐ฆ
In this episode,ย we cut through the noise and dive into what you need to know.
โ Why is this surge happening again? We'll look at the data from this past summer's outbreaks and discuss why it's crucial to stay on top of this evolving situation.
๐ก๏ธ Booster blues? Vaccine uptake is still low among at-risk populations, and there's a new booster in town. But how do you communicate that effectively to patients without sounding like a broken recordโor worse, adding to the confusion?
๐กNavigating patient conversations around booster recommendationsย ๐ and why the message has shifted. Get practical tips for identifying high-risk patients and translating NACI recommendations into action. It's not just about age; it's about timing, awareness, and making sure your patients understand why the next dose matters.
๐ Plus, we discuss how to prioritize COVID vs. flu vaccines.ย
๐ง Tune in for the latest on COVID, and more, with expert insights and a touch of humor.
Key Concepts:- COVID Surge Alert: Hospitalizations and test positivity are up again ๐ฆ ๐
- Vaccine Timing: Why itโs crucial to get your COVID shot now, with flu and RSV lurking around the corner. ๐ฏ๐
- Cross-Neutralization Explained: How the new COVID variants differ and why updated vaccines still provide protection. ๐งฌ๐ก๏ธ
- COVID Therapeutics: Paxlovid effectiveness in the context of new variants๐โโ๏ธ๐
- Patient Conversations: Strategies for helping patients understand their risks and prioritize getting vaccinated. ๐ฃ๏ธ๐ฉโโ๏ธ
ย
ย
Dr. Zain ChaglaDr.Zainย Chagla, MD MSc MD, FRCPCย is anย associateย professor at McMaster University,ย co-medicalย director ofย infectionย control at St. Josephโs Healthcare Hamilton andย aย consultant inย infectionย control at Woodstock General Hospital. Dr.ย Chaglaย isย alsoย aย teacher at McMaster Universityย where heย wonย aย clinicianย teachingย awardย inย internalย medicine andย aย young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.ย
Dr. Chagla also has aย Master of Scienceย in infectiousย diseases andย aย diploma inย tropicalย medicine andย hygiene from the London School of Hygieneย &ย Tropical Medicine.ย
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He ย hasย contributed to local, provincial, and federalย policy planning,ย andย toย severalย clinical trials on COVID-19 therapies. He hasย publishedย worksย on COVID-19 research, epidemiology, testing, and infection control. He is involved with a ย prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
ย
ย
ย...more June 12, 2023The Six Most Urgent Questions about COVID and the Journey Ahead: Part 2 โถ๏ธ๐ง๐๏ธPART 2! Tools to use on the frontline and tips to engage your patients in 60 seconds or less. We untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead withย ๐๐ซ.Alan Kaplan and Dr.Marla Shapiro who break down all ย you need to know.
โ๏ธโ๏ธWe take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?
โ๏ธโ๏ธWe delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?
โ๏ธโ๏ธWe examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.ย
โ๏ธโ๏ธWe're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?
โ๏ธโ๏ธKeeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.ย
Letโs dive in!ย
Dr.Alan Kaplanย
Dr.Alan Kaplan, MD, ย CCFP(EM), CPC(HC) is a ย family Physician practicing in York Region, Ontario, Canada.
Regional Primary Care Lead, Central Regional Cancer Program
Chairperson of the Family Physician Airways Group of Canada
Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.
Alanโs other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group
Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.
ย
Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, DFCM, University of Toronto
Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.
Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.
Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.
Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this countryโs highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.
ยVirological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
ยย
...more June 05, 2023The Six Most Urgent Questions about COVID and the Journey Ahead: Part 1 โถ๏ธ๐ง๐๏ธTodayย we untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead withย ๐๐ซ.Alan Kaplan and Dr.Marla Shapiro who break down all ย you need to know.
โ๏ธโ๏ธWe take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?
โ๏ธโ๏ธWe delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?
โ๏ธโ๏ธWe examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.ย
โ๏ธโ๏ธWe're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?
โ๏ธโ๏ธKeeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.ย
Letโs dive in!ย
Dr.Alan Kaplanย
Dr.Alan Kaplan, MD, ย CCFP(EM), CPC(HC) is a ย family Physician practicing in York Region, Ontario, Canada.
Regional Primary Care Lead, Central Regional Cancer Program
Chairperson of the Family Physician Airways Group of Canada
Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.
Alanโs other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group
Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.
ย
Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, DFCM, University of Toronto
Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.
Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.
Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.
Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this countryโs highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.
ย
ยย
...more May 15, 2023Highlights from CIC 2023 ๐๏ธ๐๏ธ๐๏ธ ๏ธ ๐๐ข๐ ๐๐๐ฐ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐ก๐๐๐ซ๐ญ ๐จ๐ ๐๐๐ง๐๐๐'๐ฌ ๐๐๐ฉ๐ข๐ญ๐๐ฅ! ๐
๐๐'๐ซ๐ ๐ญ๐ก๐ซ๐ข๐ฅ๐ฅ๐๐ ๐ญ๐จ ๐๐ง๐ง๐จ๐ฎ๐ง๐๐ ๐ญ๐ก๐๐ญ ๐ฐ๐'๐ซ๐ ๐ฅ๐๐ฎ๐ง๐๐ก๐ข๐ง๐ ๐ ๐ฉ๐จ๐๐๐๐ฌ๐ญ ๐ฌ๐๐ซ๐ข๐๐ฌ ๐ฌ๐ญ๐ซ๐๐ข๐ ๐ก๐ญ ๐๐ซ๐จ๐ฆ ๐๐ญ๐ญ๐๐ฐ๐, ๐๐ซ๐จ๐๐๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ฅ๐ฅ ๐ญ๐ก๐ ๐๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐๐๐ ๐๐๐๐.
๐๐ก๐ข๐ฌ ๐๐ฉ๐ข๐ฌ๐จ๐๐ ๐ข๐ฌย ๐ฒ๐จ๐ฎ๐ซ ๐๐ฅ๐ฅ-๐๐๐๐๐ฌ๐ฌ ๐ฉ๐๐ฌ๐ฌ ๐ญ๐จ ๐ ๐๐ฎ๐ซ๐๐ญ๐๐ ๐ฌ๐๐ฅ๐๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐ ๐ฌ๐ก๐จ๐ซ๐ญ ๐๐จ๐ง๐ฏ๐๐ซ๐ฌ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฅ๐ข๐ง๐ข๐๐ข๐๐ง ๐ญ๐ก๐จ๐ฎ๐ ๐ก๐ญ ๐ฅ๐๐๐๐๐ซ๐ฌ ย ๐๐ง๐ ๐ ๐๐ฆ๐ ๐๐ก๐๐ง๐ ๐๐ซ๐ฌ ๐ฐ๐ก๐จ ๐๐ซ๐ ๐ฌ๐ก๐๐ฉ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐จ๐ ๐ฉ๐ฎ๐๐ฅ๐ข๐ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ง๐ ๐๐๐ฒ๐จ๐ง๐.
๐๐ช๐ฃ๐ ๐๐ฃ, ๐ฉ๐ช๐ง๐ฃ ๐ช๐ฅ ๐ฉ๐๐ ๐ซ๐ค๐ก๐ช๐ข๐, ๐๐ฃ๐ ๐ฉ๐ง๐๐ฃ๐จ๐๐ค๐ง๐ข ๐ฉ๐ค๐๐๐ฉ๐๐๐ง.ย ๐ง #๐พ๐๐พ2023 #๐๐ค๐๐๐๐จ๐ฉ #๐๐ฉ๐ฉ๐๐ฌ๐
ย
ย
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 1: A Conversation with Dr.Sonia Anand MD, PhD, FRCPC
๐ก ๐ก ๐กEnsuring immunization of structurally disadvantaged populations: Black People and other people of colour
ย
Podcast Learning objectives
- โข Describe how race-disaggregated data can allow for more targeted, community-specific interventions. ย
- โข Apply novel community-specific work to engage communities to support immunization. ย
- โข Illustrate how anti-Black racism presents a pervasive barrier to engaging with preventive health care initiatives.
ย
For this mini podcast, we delve into how historical and systemic racism creates hurdles not only in understanding vaccine coverage discrepancies in Canada, but also in crafting effective, nuanced responses. We spotlight the distinctive obstacles Black and Asian communities in Canada have faced in accessing vaccines, both amidst the pandemic and prior to it. In the absence of detailed race-specific data for monitoring diseases preventable by vaccines and tracking vaccination rates, it is difficult to adequately cater to marginalized communities who face systemic barriers to healthcare access, including vaccinations. Dr.Anand unpacks this complex issue.
ย
About Dr.Sonia Anand MD, PhD, FRCPC
- Professor of Medicine and Epidemiology, McMaster
- Senior Scientist Population Health Research Institute
- Tier 1 Canada Research Chair in Ethnic Diversity and Cardiovascular Disease
- Heart and Stroke Chair in Population Health
- Associate Chair of Equity and Diversity, Department of Medicine
- Director of Chanchlani Research Centre
ย
Dr. Sonia Anand is a professor in the Department of Medicine, and the Director of the Population Genomics Program, at McMaster. She is also a senior scientist at the Population Health Research Institute at Hamilton Health Sciences. Dr. Anand holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. In 2010, Dr. Anand was named among the top 100 women by the Womenโs Executive Network for her accomplishments in research and medicine. Her current research focuses on environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease.
ย
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 2: A Conversation with ย Dr.Wayne Ghesquiere MD, FRCPC ย
๐ก ๐ก ๐กLong-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: Interim efficacy, immunogenicity and safety results at approximately 10 years after initial vaccination ย
ย
Podcast Learning objectives ย
- โข Discuss the interim efficacy of the adjuvanted recombinant zoster vaccine approximately 10 years post-vaccination.
- โข Explain the immunogenicity of the adjuvanted recombinant zoster vaccine and how it contributes to its long-term protection against herpes zoster.
- โข Evaluate the safety profile of the adjuvanted recombinant zoster vaccine based on data collected over approximately 10 years.
- โข Analyze the significance of these interim results in the context of long-term vaccine strategies against herpes zoster.
- โข Incorporate the provided insights into clinical practice and future research regarding herpes zoster vaccination strategies.
- โข Communicate effectively to patients about the long-term benefits and safety of the adjuvanted recombinant zoster vaccine
About Dr.Wayne Ghesquire MD, FRCPC
Dr Wayne Ghesquiere is a Clinical Infectious Diseases, Tropical Diseases and Internal Medicine consultant in Victoria BC as well as the former section chief for infectious diseases with the Vancouver Island Health Authority, VIHA. ย
Wayne is a Clinical Assistant Professor of Medicine with University of British Columbia. Teaches internal medicine residents and infectious diseases fellows. He is an attending physician at the Royal Jubilee and the Victoria General Hospitals in Victoria, BC. He has an inpatient and a private outpatient practice in infectious diseases.
Wayne is the chair and organizer of the annual Infectious Diseases Update in Victoria now in itโs 26th year. He is also the medical director of the Nova Travel Medicine and Immunization Clinic in Victoria.
Current areas of interests include clinical research in Hepatitis B and C antiviral therapies, new vaccines, and teaching. He is a principal investigator of many clinical trials. He has publications in peer-reviewed medical journals including the NEJM, Lancet, Clinical Infectious Diseases, CMAJ, Open Medicine and others.
ย
ย
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 3: A Conversation ย with Dr. Juthaporn Cowan, MD, FRCPC
๐ก ๐ก ๐กManagement of COVID-19 in immunocompromised patients: Are you up to date?
ย
This podcast episode is centered around COVID-19 protection strategies for immunocompromised patients. Additionally, listeners will gain up to date insight into the range of tools available for these patients' protection and treatment, including antivirals and both active and passive vaccination methods. We'll also tackle ongoing concerns regarding the management of COVID-19 amidst the persistent emergence of new variants, emphasizing the necessity of regular revisits and modifications to these management strategies.
ย
Podcast Learning Objectives ย
- Describe the medical challenges faced by immunocompromised patients and discuss the unmet need for additional protection against SARS โ CoV-2.
- ย Address the most recent data for prevention and treatment of COVID-19 in immunocompromised patients including the use of monoclonal antibodies. ย
- Share best practices for the optimum clinical management of COVID-19 in immunocompromised patients in the current Canadian context.
ย
About Dr. Juthaporn Cowan, MD, FRCPC
Assistant Professor, Associate Scientist, The Ottawa Hospital Research Institute ย
Dr.Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital.
Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa. Drs.D.William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa
ย
ย
ย
ย
...more May 03, 2023A New Deal for Canadian Healthcare with Prime Minister Justin Trudeau ๐๐๐ผ๐ฟ ๐๐ฎ๐ป๐ฎ๐ฑ๐ถ๐ฎ๐ป๐, ๐ป๐ผ๐ ๐บ๐ผ๐ฟ๐ฒ ๐๐ต๐ฎ๐ป ๐ฒ๐๐ฒ๐ฟ, ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ ๐๐ผ ๐๐ถ๐บ๐ฒ๐น๐, ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐ถ๐ ๐๐ผ๐ฝ ๐ผ๐ณ ๐บ๐ถ๐ป๐ฑ.
๐๐ง๐ต๐ฒ ๐๐ฎ๐ป๐ฎ๐ฑ๐ฎ ๐๐ฒ๐ฎ๐น๐๐ต ๐๐ฐ๐, ๐๐ต๐ถ๐ฐ๐ต ๐ผ๐๐๐น๐ถ๐ป๐ฒ๐ ๐๐ต๐ฒ ๐ป๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฝ๐ฟ๐ถ๐ป๐ฐ๐ถ๐ฝ๐น๐ฒ๐ ๐๐ต๐ฎ๐ ๐ด๐ผ๐๐ฒ๐ฟ๐ป ๐๐ต๐ฒ ๐๐ฎ๐ป๐ฎ๐ฑ๐ถ๐ฎ๐ป ๐ต๐ฒ๐ฎ๐น๐๐ต ๐๐๐๐๐ฒ๐บ, ๐๐ฎ๐ ๐ฒ๐๐๐ฎ๐ฏ๐น๐ถ๐๐ต๐ฒ๐ฑ ๐ถ๐ป ๐ญ๐ต๐ด๐ฐ.
โถ๏ธ๐ ๐น๐ผ๐ ๐ต๐ฎ๐ ๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ๐ฑ ๐๐ถ๐ป๐ฐ๐ฒ ๐๐ต๐ฒ๐ป. ย
๐ก๐ก ๐ก๐ก ๐ฟ๐ค ๐ฌ๐ ๐ฃ๐๐๐ ๐ฉ๐ค ๐จ๐ฉ๐๐ฅ ๐๐๐๐ ๐๐ฃ๐ ๐๐๐ซ๐ ๐ฉ๐๐ ๐๐ค๐ช๐ง๐๐๐ ๐ฉ๐ค ๐ง๐๐ฉ๐๐๐ฃ๐ ๐๐๐ง๐ ๐๐๐ก๐๐ซ๐๐ง๐ฎ ๐๐ฃ ๐ฉ๐๐๐จ ๐๐ค๐ช๐ฃ๐ฉ๐ง๐ฎ ๐ฉ๐ค ๐ง๐๐๐ก๐๐๐ฉ ๐ฉ๐๐ ๐๐๐๐ฃ๐๐๐ฃ๐ ๐๐๐๐ก๐ฉ๐ ๐ฃ๐๐๐๐จ ๐ค๐ ๐พ๐๐ฃ๐๐๐๐๐ฃ๐จ? ๐๐จ ๐ข๐ค๐ง๐ ๐ข๐ค๐ฃ๐๐ฎ ๐๐ค๐๐ฃ๐ ๐ฉ๐ค ๐จ๐ค๐ก๐ซ๐ ๐ฉ๐๐ ๐ฅ๐ง๐ค๐๐ก๐๐ข?
๐ง๐ต๐ฒ ๐ฟ๐ถ๐๐ธ๐ถ๐ฒ๐๐ ๐ฐ๐ต๐ผ๐ถ๐ฐ๐ฒ ๐๐ผ๐บ๐ฒ๐๐ถ๐บ๐ฒ๐ ๐ถ๐ ๐๐ผ ๐๐i๐ฐ๐ธ ๐๐ถ๐๐ต ๐๐ต๐ฒ ๐๐๐ฎ๐๐๐ ๐พ๐๐ผ, ๐ฒ๐๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น๐น๐ ย ๐๐ต๐ฒ๐ป ๐๐ฒ ๐๐ฝ๐ฒ๐ฎ๐ธ ๐ผ๐ณ ๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ.
ย
๐๐ฌ The premiers and the prime minister reached a new 10 year healthcare funding deal totaling $196 billion, with $46 billion in new funding with a tailored approach to the unique healthcare needs of each province and territory via bilateral deals. Provinces and territories in return must commit to health-care reform and improve transparency around data collection.
๐โถ๏ธ We sit down with Canadian Prime Minister, Justin Trudeau, to chat about his vision for healthcare, opportunities and challenges, and what building accountability and innovation into these new bilateral healthcare agreements with each province and territory will, and can look like. ย
๐๐๏ธ ๐จ๏ธย Whether you practice in BC or Newfoundland, ๐ฌ๐๐๐ฉ๐๐๐ง ๐ฎ๐ค๐ช'๐ง๐ ๐ pharmacist, physician, nurse, nurse practitioner, or allied health professional, tune in to hear the PMโs personal message for our listeners and how the next generation of leaders in healthcare can play a meaningful role in shaping future of our healthcare system.
ย
The Right Honourable Justin Trudeau, Prime Minister of Canada
Justin Trudeau ย is Canadaโs 23rd Prime Minister.
Justinโs vision of Canada is a country where everyone has a real and fair chance to succeed. His experiences as a teacher, father, leader, and advocate for youth have shaped his dedication to Canadians โ and his commitment to make Canada a place where everyone has the opportunities they need to thrive.
The oldest of three boys, Justin grew up with the profound influence of his father, Pierre Elliott Trudeau, and his mother, Margaret Trudeau. He was raised speaking both French and English and has family roots in both Eastern and Western Canada. This background helped spark his passion for public service and shaped his conviction that diversity is Canadaโs strength.
Justin studied literature at McGill University, graduating with a Bachelor of Arts (B.A.) in 1994. He went on to complete the University of British Columbiaโs education program, and spent several years teaching French, math, and other subjects in Vancouver. Teaching allowed him to make a positive impact in the lives of young people. He remains committed to hearing the voices of young Canadians, from the classroom to Parliament Hill.
Before entering politics, Justin served as the Chair of Katimavik, on the board for the Canadian Avalanche Foundation, and as an advocate for young people and the environment. As a speaker at events and conferences around the country, he encouraged young people to engage with the issues important to them and participate as active citizens. These experiences made it increasingly clear to him that the issues young Canadians care about โ education, the environment, and their generation's economic prospects โ needed a stronger voice.
Justin entered politics to make change that would better serve all Canadians. In 2007, he built a community-based, grassroots campaign to win the Liberal Party nomination in the Montrรฉal riding of Papineau. He was elected in 2008, and re-elected in 2011, 2015, and 2019.
Justin was elected Leader of the Liberal Party in April 2013. His leadership campaign focused on building a new, truly national movement of progressive Canadians, bringing hundreds of thousands of Canadians into politics, most for the first time. He worked closely with his team to build a plan to create jobs, grow the economy, protect the environment, and strengthen the middle class. With Justinโs leadership, the Liberal plan emphasized fair economic opportunity for everyone, respect for and promotion of freedom and diversity, and a more democratic government that truly represents Canadians.
On October 19, 2015, Justin led his party to victory, winning a majority government with seats in every province and territory across the country. He was sworn in on November 4, 2015.
On October 21, 2019, Justin led the Liberal Party to re-election, earning a second mandate from Canadians.
As Prime Minister, Justin leads a government that works hard every day to continue moving Canada forward.ย His team is focused on creating good middle class jobs, making life more affordable, keeping Canadaโs communities safe, fighting climate change, and moving forward on reconciliation with Indigenous peoples. A proud feminist, Justin appointed Canadaโs first gender balanced Cabinet.
...more November 18, 2022BC Premier David Eby on Healthcare in BC ๐ฌNOTE: Episode recorded in early Fall (September) as leadership candidate prior to David officially becoming Premier. ******
โ๏ธ ย Today, David Eby was sworn in as British Columbiaโs 37th premier.
๐จ๏ธ We sit down with Premier Eby to discuss his plans for the Province's #๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐๐๐๐๐ฒ๐บ, ๐ถ๐ป๐ฐ๐น๐๐ฑ๐ถ๐ป๐ด everything from ๐ฒ๐ป๐ต๐ฎ๐ป๐ฐ๐ถ๐ป๐ด #patient ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ by expanding ๐๐ต๐ฒ ๐๐๐ถ๐๐ฒ ๐ผ๐ณ ๐๐ฒ๐ฟ๐๐ถ๐ฐ๐ฒ๐ #๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ถ๐๐๐ ๐ฎ๐ป๐ฑ ๐ผ๐๐ต๐ฒ๐ฟ #๐๐๐ฃ๐ ๐ฐ๐ผ๐๐น๐ฑ ๐ฝ๐ฟ๐ผ๐๐ถ๐ฑ๐ฒ, reforming primary care, and if outdated legislation around patient rights is meeting the needs of today's patients. ย
๐ฌ ๐๏ธ ๐๐'๐ ๐ป๐ผ๐ ๐ฑ๐ถ๐ณ๐ณ๐ถ๐ฐ๐๐น๐ ๐๐ผ ๐ฎ๐ฟ๐ด๐๐ฒ ๐๐ต๐ฎ๐ ๐ฎ ๐๐ฟ๐ฎ๐ฑ๐ถ๐๐ถ๐ผ๐ป๐ฎ๐น ๐บ๐ถ๐ป๐ฑ๐๐ฒ๐ ๐ฐ๐ฎ๐ป ๐ฏ๐ฒ ๐ฐ๐ต๐ฎ๐น๐น๐ฒ๐ป๐ด๐ถ๐ป๐ด ๐๐ผ ๐๐ฎ๐ฐ๐ธ๐น๐ฒ ๐๐ต๐ฒ๐ป ๐๐ฒ ๐๐ต๐ถ๐ป๐ธ ๐ฎ๐ฏ๐ผ๐๐ #๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐ฑ๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐ ๐ฐ๐ฒ๐ป๐๐ฒ๐ฟ๐ฒ๐ฑ ๐ฐ๐ฎ๐ฟ๐ฒ ๐ถ๐ป ๐๐ฎ๐ป๐ฎ๐ฑ๐ฎ. ๐๐ป ๐ฎ ๐๐ถ๐บ๐ฒ ๐ผ๐ณ ๐ฐ๐ฟ๐ถ๐๐ถ๐, ๐ฑ๐ผ ๐๐ฒ ๐ป๐ฒ๐ฒ๐ฑ ๐ฎ ๐ณ๐๐ป๐ฑ๐ฎ๐บ๐ฒ๐ป๐๐ฎ๐น ๐๐ต๐ถ๐ณ๐ ๐ฎ๐ฏ๐ผ๐๐ ๐ต๐ผ๐ ๐๐ฒ ๐๐ต๐ถ๐ป๐ธ ๐ฎ๐ฏ๐ผ๐๐ #๐ฝ๐ฟ๐ถ๐บ๐ฎ๐ฟ๐ ๐ฐ๐ฎ๐ฟ๐ฒ ๐ฎ๐ป๐ฑ #๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐ ๐ฎ๐๐๐ฎ๐ฐ๐ต๐บ๐ฒ๐ป๐?
ย
Questions we ask: ย
ย
๐ก๐ก ๐ซ๐๐๐ ๐๐๐๐๐ ๐ช๐๐๐๐ ๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐ ๐๐ ๐ ๐ฎ๐ท, ๐๐ ๐ ๐๐๐ ๐๐๐๐๐ ๐ช๐๐๐๐ ๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐ ๐๐ ๐๐๐๐-๐๐๐๐๐๐๐ #๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐๐๐-๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐ ๐๐๐ ๐๐๐ ๐๐ ๐๐๐๐๐ #๐๐๐๐๐๐๐ ๐๐๐๐ service ๐๐๐๐ ๐๐๐๐? ๐ฌ๐ซ๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐? ย
ย
โถ๏ธย ๐ฐ๐ ๐ฐ ๐๐๐ 50 ๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐ ๐๐๐ 20 ๐๐๐๐๐๐๐๐ ๐ ๐ ๐๐, ๐๐๐ ๐๐ ๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ #๐๐๐๐? ๐ฐ๐ ๐๐๐๐ ๐๐๐๐ ๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐? ย ๐ก๐ก ๐๐ถ๐ป๐ธ๐ถ๐ป๐ด #๐ต๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ #๐ฝ๐ฟ๐ผ๐๐ถ๐ฑ๐ฒ๐ฟ ๐ฟ๐ฒ๐บ๐๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐๐ถ๐๐ต ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ผ๐ณ #๐ฐ๐ฎ๐ฟ๐ฒ, ๐๐ฒ๐ฟ๐๐ถ๐ฐ๐ฒ ๐ฑ๐ฒ๐น๐ถ๐๐ฒ๐ฟ๐ ๐บ๐ฒ๐๐ฟ๐ถ๐ฐ๐, ๐ฎ๐ป๐ฑ #๐ผ๐๐๐ฐ๐ผ๐บ๐ฒ๐ ๐ต๐ฎ๐ ๐ฏ๐ฒ๐ฒ๐ป ๐ฎ ๐ฐ๐ผ๐ป๐๐ฒ๐ฟ๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ต๐ฎ๐'๐ ๐ฏ๐ฒ๐ฒ๐ป ๐ต๐ฎ๐ฑ ๐ณ๐ผ๐ฟ ๐๐ฒ๐ฎ๐ฟ๐ ๐ฎ๐ฐ๐ฟ๐ผ๐๐ ๐๐ฎ๐ป๐ฎ๐ฑ๐ฎ.๐จ๐ฆ
ย
๐๏ธ๐ช๐ต๐ฎ๐ ๐๐ถ๐น๐น ๐ถ๐ ๐๐ฎ๐ธ๐ฒ ๐๐ผ ๐บ๐ฎ๐ธ๐ฒ ๐๐ต๐ฒ ๐๐ต๐ถ๐ณ๐ broadly across our healthcare ๐ณ๐ฟ๐ผ๐บ #๐๐ผ๐น๐๐บ๐ฒ ๐๐ผ #๐๐ฎ๐น๐๐ฒ ๐ฏ๐ฎ๐๐ฒ๐ฑ ๐ฐ๐ฎ๐ฟ๐ฒ and why are we not there yet?
ย
ABOUT DAVID EBY, KCย
David Eby, K.C.David Eby is the MLA for Vancouver-Point Grey, first elected in 2013.
Before he was elected, David was the Executive Director of the BC Civil Liberties Association, an adjunct professor of law at the University of British Columbia, president of the HIV/AIDS Legal Network, and served on the Vancouver Foundation's Health and Social Development Committee.
An award-winning human rights lawyer, he has been repeatedly recognized in local media as one of British Columbia's most effective advocates and has appeared at all levels of court in BC.
His years of legal advocacy at Pivot Legal Society to protect the human rights and dignity of homeless and under-housed residents of Vancouver's Downtown Eastside were recognized in 2011 by the UN Association in Canada and the B.C. Human Rights Coalition with their annual award.
...more October 18, 2022Climate Change, Communication and Mobilizing Public Health with Canada's Top Doctor: Dr.Theresa Tam โถ๏ธ ย ๐จ๏ธ We are excited to sit down with Canada's Chief Public Health Officer, Dr.Theresa Tam, to discuss her personal thoughts about how this pandemic has ย reshaped how we think about public health's role and new opportunities to synergize with frontline healthcare providers. ย
๐ฌ๐๏ธ Often climate change is not a top of mind issue ย when it comes to healthcare planning and resource allocation. In anticipation of Dr.Tam's upcoming Annual report, we deep dive into how public health is building in plans to address climate change, extreme weather event, and the changing endemicity of transmissible diseases as a result.
๐ก ย You also don't want to miss Dr.Tam's secret talent.
๐ฌNOTE: Links added below to Dr.Theresa Tam's Annual Report: Mobilizing Public Health Action on Climate Change in Canada as episode was recorded prior to release******
https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/state-public-health-canada-2022/report.html
--------
๐ข EPISODE TIME STAMPS๐ข
02:08 ย Intro
ย
04:21 ย Dr.Tam's journey from practitioner to public health leader ย
ย
07:48 ย Dealing with being a very public face and the pressures that come with it
ย
14:55 Planning for the future of public health in Canada and the next "x" factor
ย
21:18 Addressing gaps and needs in healthcare communication ย
ย
28:36 Mapping synergy betwen frontline healthcare providers and public health in Canada
ย
31:03 At the intersection of climate change and public health planning
ย
35:09 What does Dr. Tam ย have to say to the next generation of leaders on the front line and potentially leaders in public ย
ย ย ย ย ย ย health?
--------
๐๏ธ ABOUT DR.THERESA TAM
Dr. Theresa Tam was named Canada's Chief Public Health Officer on June 26, 2017. She is a paediatric infectious disease specialist with expertise in immunization, emergency preparedness and global health security.
Dr. Tam obtained her medical degree from the University of Nottingham in the U.K. She completed her paediatric residency at the University of Alberta and her fellowship in paediatric infectious diseases at the University of British Columbia.
She is a Fellow of the Royal College of Physicians and Surgeons of Canada and has over 55 peer-reviewed journal publications in public health. She is also a graduate of the Canadian Field Epidemiology Program.
Dr. Tam has held several senior leadership positions at the Public Health Agency of Canada, including as the Deputy Chief Public Health Officer and the Assistant Deputy Minister for Infectious Disease Prevention and Control. During her 25 years in public health, she provided technical expertise and leadership on new initiatives to improve communicable disease surveillance, enhance immunization programs, strengthen health emergency management and laboratory biosafety and biosecurity. She has played a leadership role in Canada's response to public health emergencies including severe acute respiratory syndrome (SARS), pandemic influenza H1N1 and Ebola.
Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.
...more October 03, 2022Covid-19 Bivalent Boosters โ All You Need to Know with Dr.Zain Chagla Your COVID vaccine is getting a makeover (well kind of).
Freshly formulated updated Omicron-specific COVID-19 vaccines are now available.
These ย new bivalent booster shots rolling out across Canada are specifically tailored to match currently circulating COVID omicron variants and are thought to provide enhanced protection against newer versions of SARS-CoV-2 than our earlier shots. Uptake of booster vaccines has not been anywhere near as high as the initial vaccines.
โถ๏ธ๐ง ๐๏ธ ๐๐ ๐ฌ๐ข๐ญ ๐๐จ๐ฐ๐ง ๐ฐ๐ข๐ญ๐ก ๐ฅ๐๐๐๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซt, ๐๐ซ.๐๐๐ข๐ง ๐๐ก๐๐ ๐ฅ๐ who breaks down all ย you need to know about (in less than 36 minutes):ย
โ๏ธโ๏ธHow do you approach and recommend the updated bivalent COVID-19 booster to eligible patients
โ๏ธโ๏ธHow should you be framing the efficacy conversation in relation to this bivalent booster-antibody data vs clinical effectiveness
โ๏ธโ๏ธStrategies to increase booster uptake in clinical practice
โ๏ธโ๏ธKey practicalities of the vaccine and how this would fit into your daily practice? ย
โ๏ธโ๏ธAre breakthrough infections less likely with this updated bivalent booster? ย
โ๏ธโ๏ธWill this booster still work if the virus mutates again and thereโs a new variant?
โ๏ธโ๏ธ What does the healthcare provider ย need to know from this discussion to communicate with a patient the next day? ย
ย
Dr. Zain ChaglaDr.Zainย Chagla, MD MSc MD, FRCPCย is anย associateย professor at McMaster University,ย co-medicalย director ofย infectionย control at St. Josephโs Healthcare Hamilton andย aย consultant inย infectionย control at Woodstock General Hospital. Dr.ย Chaglaย isย alsoย aย teacher at McMaster Universityย where heย wonย aย clinicianย teachingย awardย inย internalย medicine andย aย young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.ย
Dr. Chagla also has aย Master of Scienceย in infectiousย diseases andย aย diploma inย tropicalย medicine andย hygiene from the London School of Hygieneย &ย Tropical Medicine.ย
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He ย hasย contributed to local, provincial, and federalย policy planning,ย andย toย severalย clinical trials on COVID-19 therapies. He hasย publishedย worksย on COVID-19 research, epidemiology, testing, and infection control. He is involved with a ย prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
ย
ย
ย...more August 23, 2022Long Story Short? Long COVID and the Role of Vaccination with Dr.Angela Cheung and Dr.Zain Chagla PART 2 ๐๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ฅ๐ข๐ฏ๐ข๐ง๐ ๐ฐ๐ข๐ญ๐ก ๐ฉ๐จ๐ฌ๐ญ-๐๐๐ฎ๐ญ๐ ๐ฌ๐๐ช๐ฎ๐๐ฅ๐๐ ๐จ๐ ย ๐๐๐๐-๐๐จ๐-๐ ๐ข๐ง๐๐๐๐ญ๐ข๐จ๐ง (๐๐๐๐), ๐๐๐ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐, ๐ฅ๐ข๐ฏ๐ ๐ฐ๐ข๐ญ๐ก ๐ ๐ฐ๐ข๐๐ ๐๐ซ๐ซ๐๐ฒ ๐จ๐ ๐ฌ๐ฒ๐ฆ๐ฉ๐ญ๐จ๐ฆ๐ฌ, ๐ซ๐๐ง๐ ๐ข๐ง๐ ๐๐ซ๐จ๐ฆ ๐ฆ๐ข๐ฅ๐ ๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ๐ฒ ๐๐๐๐ข๐ฅ๐ข๐ญ๐๐ญ๐ข๐ง๐ .
๐๏ธ๐๏ธ๐๏ธ ๐๐ ๐ฌ๐ข๐ญ ๐๐จ๐ฐ๐ง ๐ฐ๐ข๐ญ๐ก ๐ ๐ฅ๐๐๐๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ฌ, ๐๐ซ.๐๐ง๐ ๐๐ฅ๐ ๐๐ก๐๐ฎ๐ง๐ ๐๐ง๐ ๐๐ซ.๐๐๐ข๐ง ๐๐ก๐๐ ๐ฅ๐, ๐ญ๐จ ๐ฌ๐๐๐ค ๐ฌ๐จ๐ฆ๐ ๐๐ฅ๐๐ซ๐ข๐ญ๐ฒ ๐๐๐จ๐ฎ๐ญ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐โ๐ฌ ๐๐๐๐๐๐ญ๐ฌ, ๐ฉ๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ๐ฌ, ๐ฌ๐๐ซ๐๐๐ง๐ข๐ง๐ , ๐๐ง๐ ๐ก๐จ๐ฐ ๐ญ๐ก๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ฆ๐ข๐ ๐ก๐ญ ๐ข๐ฆ๐ฉ๐๐๐ญ ๐๐๐ง๐๐๐โ๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐๐ซ๐ ๐ฌ๐ฒ๐ฌ๐ญ๐๐ฆ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐.ย
โถ๏ธ๐ง ๐๏ธ Dr.Angela M. Cheung and Dr.Zain Chagla breakdown what you need to know about:
ย
โ๏ธโ๏ธโ๏ธ New ๐ง๐๐จ๐๐๐ง๐๐ exploring how recent you've had your last dose of #๐พ๐๐๐๐ฟ-19 ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ค๐ฃ and the link ๐ฌ๐๐ฉ๐ ๐ก๐ค๐ฃ๐ #๐พ๐๐๐๐ฟ ๐จ๐ฎ๐ข๐ฅ๐ฉ๐ค๐ข ๐ข๐๐ฉ๐๐๐๐ฉ๐๐ค๐ฃ. ย
โ๏ธโ๏ธโ๏ธC๐ช๐ง๐ง๐๐ฃ๐ฉ ๐๐ซ๐๐๐๐ฃ๐๐ ๐๐ฃ๐ ๐ช๐ฃ๐๐๐ง๐จ๐ฉ๐๐ฃ๐๐๐ฃ๐ ๐ค๐ ๐พ๐๐๐๐ฟ ๐ง๐๐๐ฃ๐๐๐๐ฉ๐๐ค๐ฃ ๐๐ฃ๐ ๐ฉ๐๐ ๐ง๐๐จ๐ ๐ค๐ ๐๐๐ซ๐๐ก๐ค๐ฅ๐๐ฃ๐ ๐ก๐ค๐ฃ๐-๐พ๐๐๐๐ฟ
โ๏ธโ๏ธโ๏ธ ๐๐๐ก๐ฅ๐๐ฃ๐ ๐ฎ๐ค๐ช๐ง ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐ช๐ฃ๐๐๐ง๐จ๐ฉ๐๐ฃ๐ ๐ฉ๐๐ ๐ง๐๐จ๐ ๐ค๐ ๐๐๐ซ๐๐ก๐ค๐ฅ๐๐ฃ๐ ๐ก๐ค๐ฃ๐ ๐พ๐๐๐๐ฟ ๐จ๐ฎ๐ข๐ฅ๐ฉ๐ค๐ข๐จ ๐๐ฃ ๐๐๐ช๐ก๐ฉ๐จ ๐ฌ๐๐ฉ๐ ๐๐ผ๐๐-๐พ๐ค๐-2 ๐๐ฃ๐๐๐๐ฉ๐๐ค๐ฃ ๐๐๐๐ค๐ง๐ ๐๐ฃ๐ ๐๐๐ฉ๐๐ง ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ค๐ฃ.
ย
Dr. Angela CheungDr. Angela Cheung is the KY and Betty Ho Chair of Integrative Medicineย at the University of Toronto and is a professor of medicine and internal medicine specialist, as well as a senior scientist at the University Health Network in Toronto.ย Dr.Cheung holds a Tier 1 Canada Research Chairย and She obtained her M.D. degree from Johns Hopkins University School of Medicine, and her Ph.D. degree from Harvard University.ย
Dr.Cheung is the co-lead of CANCOV (Canadian COVID-19 Prospective Cohort Study) as well as RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trial, a Canada-wide, open-label, pragmatic, adaptive randomized clinical trial platform to assess the effectiveness of various interventions in patients with lingering symptoms of COVIDโ19.
ย
ย
Dr. Zain ChaglaDr.Zainย Chagla, MD MSc MD, FRCPCย is anย associateย professor at McMaster University,ย co-medicalย director ofย infectionย control at St. Josephโs Healthcare Hamilton andย aย consultant inย infectionย control at Woodstock General Hospital. Dr.ย Chaglaย isย alsoย aย teacher at McMaster Universityย where heย wonย aย clinicianย teachingย awardย inย internalย medicine andย aย young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.ย
Dr. Chagla also has aย Master of Scienceย in infectiousย diseases andย aย diploma inย tropicalย medicine andย hygiene from the London School of Hygieneย &ย Tropical Medicine.ย
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He ย hasย contributed to local, provincial, and federalย policy planning,ย andย toย severalย clinical trials on COVID-19 therapies. He hasย publishedย worksย on COVID-19 research, epidemiology, testing, and infection control. He is involved with a ย prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
Resources to further explore:
- The Canadian COVID-19 Prospective Cohort Study (CANCOV)ย
- RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trial
- Lancet: Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
ย
ย
ย
...more August 16, 2022Long Story Short? Long COVID and the Role of Vaccination with Dr.Angela Cheung and Dr.Zain Chagla ๐๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ฅ๐ข๐ฏ๐ข๐ง๐ ๐ฐ๐ข๐ญ๐ก ๐ฉ๐จ๐ฌ๐ญ-๐๐๐ฎ๐ญ๐ ๐ฌ๐๐ช๐ฎ๐๐ฅ๐๐ ๐จ๐ ย ๐๐๐๐-๐๐จ๐-๐ ๐ข๐ง๐๐๐๐ญ๐ข๐จ๐ง (๐๐๐๐), ๐๐๐ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐, ๐ฅ๐ข๐ฏ๐ ๐ฐ๐ข๐ญ๐ก ๐ ๐ฐ๐ข๐๐ ๐๐ซ๐ซ๐๐ฒ ๐จ๐ ๐ฌ๐ฒ๐ฆ๐ฉ๐ญ๐จ๐ฆ๐ฌ, ๐ซ๐๐ง๐ ๐ข๐ง๐ ๐๐ซ๐จ๐ฆ ๐ฆ๐ข๐ฅ๐ ๐ญ๐จ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ๐ฒ ๐๐๐๐ข๐ฅ๐ข๐ญ๐๐ญ๐ข๐ง๐ .
๐๏ธ๐๏ธ๐๏ธ ๐๐ ๐ฌ๐ข๐ญ ๐๐จ๐ฐ๐ง ๐ฐ๐ข๐ญ๐ก ๐ ๐ฅ๐๐๐๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ฌ, ๐๐ซ.๐๐ง๐ ๐๐ฅ๐ ๐๐ก๐๐ฎ๐ง๐ ๐๐ง๐ ๐๐ซ.๐๐๐ข๐ง ๐๐ก๐๐ ๐ฅ๐, ๐ญ๐จ ๐ฌ๐๐๐ค ๐ฌ๐จ๐ฆ๐ ๐๐ฅ๐๐ซ๐ข๐ญ๐ฒ ๐๐๐จ๐ฎ๐ญ ๐ฅ๐จ๐ง๐ ๐๐๐๐๐โ๐ฌ ๐๐๐๐๐๐ญ๐ฌ, ๐ฉ๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ๐ฌ, ๐ฌ๐๐ซ๐๐๐ง๐ข๐ง๐ , ๐๐ง๐ ๐ก๐จ๐ฐ ๐ญ๐ก๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ฆ๐ข๐ ๐ก๐ญ ๐ข๐ฆ๐ฉ๐๐๐ญ ๐๐๐ง๐๐๐โ๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐๐ซ๐ ๐ฌ๐ฒ๐ฌ๐ญ๐๐ฆ ๐ข๐ง ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐.ย
๐ก ๐ก ๐ก ๐๐๐๐ฉ ๐๐๐ฃ ๐๐ ๐๐ค๐ฃ๐ ๐ฉ๐ค ๐๐๐ก๐ฅ ๐ฎ๐ค๐ช๐ง ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐ฌ๐๐ฉ๐ ๐ก๐ค๐ฃ๐ ๐พ๐๐๐๐ฟ?
๐ก ๐ก ๐ฟ๐ค๐๐จ ๐๐๐๐ฃ๐ ๐๐ช๐ก๐ก๐ฎ ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ ๐ค๐ง ๐๐ค๐ค๐จ๐ฉ๐๐ ๐ข๐๐ฉ๐๐๐๐ฉ๐ ๐ฉ๐๐ ๐ง๐๐จ๐ ๐ค๐ ๐๐ค๐ฃ๐ฉ๐ง๐๐๐ฉ๐๐ฃ๐ ๐๐๐๐ ๐พ๐๐๐๐ฟ ๐ค๐ง ๐ข๐๐ฉ๐๐๐๐ฉ๐ ๐ฉ๐๐ ๐จ๐๐ฆ๐ช๐๐ก๐๐ ๐ค๐ ๐๐ฉ? ๐ฟ๐ค๐๐จ ๐ฉ๐๐ ๐ง๐๐๐๐ฃ๐๐ฎ ๐ค๐ ๐ฎ๐ค๐ช๐ง ๐พ๐๐๐๐ฟ ๐๐ค๐ค๐จ๐ฉ๐๐ง ๐ค๐ง ๐ซ๐๐๐๐๐ฃ๐๐ฉ๐๐ค๐ฃ ๐๐ก๐จ๐ค ๐ฅ๐ก๐๐ฎ ๐ ๐ง๐ค๐ก๐? ย
๐ก ย ๐๐ค๐ฌ ๐จ๐๐ค๐ช๐ก๐ ๐ฌ๐ ๐๐ ๐ฉ๐๐๐ฃ๐ ๐๐ฃ๐ ๐๐๐ค๐ช๐ฉ ๐๐ค๐ข๐ข๐ช๐ฃ๐๐๐๐ฉ๐๐ฃ๐ ๐ฉ๐๐ ๐๐ค๐ฃ๐๐๐ฅ๐ฉ ๐ค๐ ๐ง๐๐จ๐ , ๐๐ฃ๐ ๐๐ง๐๐ข๐๐ฃ๐ ๐ง๐๐จ๐ ๐ฉ๐ค ๐ค๐ช๐ง ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐๐ฃ ๐ฉ๐๐ ๐๐ค๐ฃ๐ฉ๐๐ญ๐ฉ ๐ค๐ ๐ก๐ค๐ฃ๐ ๐พ๐๐๐๐ฟ?
Dr. Angela CheungDr. Angela Cheung is the KY and Betty Ho Chair of Integrative Medicineย at the University of Toronto and is a professor of medicine and internal medicine specialist, as well as a senior scientist at the University Health Network in Toronto.ย Dr.Cheung holds a Tier 1 Canada Research Chairย and She obtained her M.D. degree from Johns Hopkins University School of Medicine, and her Ph.D. degree from Harvard University.ย
Dr.Cheung is the co-lead of CANCOV (Canadian COVID-19 Prospective Cohort Study) as well as RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trial, a Canada-wide, open-label, pragmatic, adaptive randomized clinical trial platform to assess the effectiveness of various interventions in patients with lingering symptoms of COVIDโ19.
ย
ย
Dr. Zain ChaglaDr.Zainย Chagla, MD MSc MD, FRCPCย is anย associateย professor at McMaster University,ย co-medicalย director ofย infectionย control at St. Josephโs Healthcare Hamilton andย aย consultant inย infectionย control at Woodstock General Hospital. Dr.ย Chaglaย isย alsoย aย teacher at McMaster Universityย where heย wonย aย clinicianย teachingย awardย inย internalย medicine andย aย young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.ย
Dr. Chagla also has aย Master of Scienceย in infectiousย diseases andย aย diploma inย tropicalย medicine andย hygiene from the London School of Hygieneย &ย Tropical Medicine.ย
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He ย hasย contributed to local, provincial, and federalย policy planning,ย andย toย severalย clinical trials on COVID-19 therapies. He hasย publishedย worksย on COVID-19 research, epidemiology, testing, and infection control. He is involved with a ย prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
Resources to further explore:
- The Canadian COVID-19 Prospective Cohort Study (CANCOV)ย
- RECLAIM (REcovering from COVIDโ19 Lingering symptoms Adaptive Integrative Medicine) trial
- Lancet: Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
ย
ย
ย
...more
FAQs about Findmyvaccine:
How many episodes does Findmyvaccine have?
The podcast currently has 25 episodes available.